The story of Viagra presents a intricate picture for investors. While the initial launch generated massive returns, the expiration of its patent opened the avenue to cheaper competitors, dramatically reducing sales. https://bookmarketmaven.com/story22512462/sildenafil-and-big-pharma-a-precarious-opportunity